MedTrace Logo

The Neuro Zti Cochlear Implant System Efficacy and Safety in Adults

NCT02941627 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 53

Last updated 2021-11-10

Study results available
· View outcomes & findings →

Summary

The purpose of the study is to assess the efficacy and the safety profile of the Neuro Cochlear Implant System (CIS) in adults with severe-to-profound hearing loss.

Conditions

  • Hearing Loss, Sensorineural
  • Hearing Loss, Cochlear
  • Deafness

Interventions

DEVICE

Neuro Zti

Cochlear implant

DEVICE

Neuro One

Sound processor

Sponsors & Collaborators

  • Oticon Medical

    lead INDUSTRY

Principal Investigators

  • David Schramm, MD · Ottawa Civic Hospital

  • Daniel Philippon, MD · CHU de Quebec

  • Joseph Chen, MD · Sunnybrook Hospital -Toronto

  • Nael Shoman, MD · Royal University Hospital, Saskatoon

  • David P. Morris, MD · Nova Scotia Hearing and Speech Centres - Halifax

  • Per Cayé Thomasen, MD · Gentofte Hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-02-02
Primary Completion
2019-11-22
Completion
2019-11-22

Countries

  • Canada
  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02941627 on ClinicalTrials.gov